We are live on ! Find out more
P

&Partners Portfolio holdings

AUM $20.2B
1-Year Est. Return 19.79%
This Fund
S&P 500
This Quarter Est. Return
+2.42%
1 Year Est. Return
+19.79%
3 Year Est. Return
+62.7%
5 Year Est. Return
+67.16%
10 Year Est. Return
AUM
$2.28B
AUM Growth
+$1.56B
Cap. Flow
+$1.51B
Cap. Flow %
66.23%
Top 10 Hldgs %
23.13%
Holding
926
New
435
Increased
440
Reduced
23
Closed
12

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$66.8M
2
AAPL icon
Apple
AAPL
+$54.9M
3
IVV icon
iShares Core S&P 500 ETF
IVV
+$50.4M
4
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$32.9M
5
NVDA icon
NVIDIA
NVDA
+$29.1M

Sector Composition

Rank Sector Weight
1 Technology 17.11%
2 Financials 7.61%
3 Healthcare 6.47%
4 Industrials 5.45%
5 Consumer Discretionary 5.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BSCQ icon
451
Invesco BulletShares 2026 Corporate Bond ETF
BSCQ
$3.67B
$672K 0.03%
35,043
+18,391
+110% +$353K
VOOV icon
452
Vanguard S&P 500 Value ETF
VOOV
$6.58B
$661K 0.03%
+3,760
New +$663K
AG icon
453
First Majestic Silver
AG
$8.05B
$661K 0.03%
+111,628
New +$773K
TER icon
454
Teradyne
TER
$54.8B
$660K 0.03%
+4,449
New +$565K
TAIL icon
455
Cambria Tail Risk ETF
TAIL
$145M
$659K 0.03%
56,857
+14,791
+35% +$175K
FIS icon
456
Fidelity National Information Services
FIS
$21.5B
$657K 0.03%
8,721
+4,573
+110% +$339K
PPL
457
PPL Corp
PPL
$27.3B
$657K 0.03%
+23,751
New +$666K
WST icon
458
West Pharmaceutical
WST
$23.1B
$654K 0.03%
+1,986
New +$702K
CP icon
459
Canadian Pacific Kansas City
CP
$82B
$641K 0.03%
8,137
+4,753
+140% +$387K
JKHY icon
460
Jack Henry & Associates
JKHY
$10.7B
$638K 0.03%
+3,845
New +$638K
SGOV icon
461
iShares 0-3 Month Treasury Bond ETF
SGOV
$98.6B
$637K 0.03%
+6,325
New +$636K
RCL icon
462
Royal Caribbean
RCL
$78.7B
$635K 0.03%
3,981
+1,613
+68% +$232K
CDW icon
463
CDW
CDW
$17.1B
$631K 0.03%
+2,817
New +$653K
SKYY icon
464
First Trust Cloud Computing ETF
SKYY
$2.74B
$629K 0.03%
6,584
+1,141
+21% +$106K
VGSH icon
465
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
$629K 0.03%
+10,843
New +$627K
REGN icon
466
Regeneron Pharmaceuticals
REGN
$68.8B
$627K 0.03%
+597
New +$579K
VFH icon
467
Vanguard Financials ETF
VFH
$13.3B
$626K 0.03%
+6,264
New +$625K
SHOP icon
468
Shopify
SHOP
$148B
$625K 0.03%
+9,462
New +$628K
TROW icon
469
T. Rowe Price
TROW
$25B
$625K 0.03%
5,417
+1,140
+27% +$131K
THO icon
470
Thor Industries
THO
$3.99B
$623K 0.03%
+6,629
New +$663K
DGX icon
471
Quest Diagnostics
DGX
$25.1B
$620K 0.03%
+4,563
New +$625K
KEYS icon
472
Keysight
KEYS
$54.5B
$620K 0.03%
+4,532
New +$662K
ZBRA icon
473
Zebra Technologies
ZBRA
$12.4B
$618K 0.03%
+2,001
New +$608K
DGS icon
474
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
$1.7B
$618K 0.03%
12,006
+3,037
+34% +$156K
EWW icon
475
iShares MSCI Mexico ETF
EWW
$1.89B
$612K 0.03%
10,805
+3,056
+39% +$196K

Similar funds

&Partners's Q2 2024 Portfolio in Review

As of Q2 2024, &Partners held 926 positions worth $2.28B, up 215% from $726M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

&Partners deployed $1.51B of net new capital in Q2 2024, opening 435 new positions and adding to 440 existing holdings. Its largest new stake was ALPS O'Shares U.S. Quality Dividend ETF: 218,762 shares worth $10.9M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Vanguard Large-Cap ETF, an estimated $10M trimmed.

  • &Partners's largest Q2 2024 buy was ALPS O'Shares U.S. Quality Dividend ETF: 218,762 shares worth $10.9M.
  • &Partners added most to Microsoft in Q2 2024, an estimated $66.8M increase.
  • &Partners's biggest Q2 2024 reduction was Vanguard Large-Cap ETF, cutting an estimated $10M.
  • &Partners fully exited Darling Ingredients in Q2 2024, selling an estimated $390K.
  • &Partners's ten largest holdings make up 23% of its $2.28B portfolio in Q2 2024.
  • &Partners opened 435 new positions and closed 12 in Q2 2024.
  • &Partners's portfolio value rose 215% quarter-over-quarter to $2.28B.

Based on &Partners's 13F filing for Q2 2024, filed 24 Jul 2024.